XWELL Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Monitoring Framework
Key Performance Indicators
Total Revenue Annually29.2M
Cash and Cash Equivalents Quarterly2.6M
Working Capital Surplus Quarterly-7M
Watch Items
- AI-Powered Biosecurity Forecasting Platform DeploymentTrigger: Successful integration of PieQ predictive intelligence layer for the June 2026 World CupAction: Monitor contract expansions with the CDC and international travel hubs
- Capital Structure Dilution from Series H Preferred StockTrigger: Conversion of Series H Preferred Stock or exercise of accompanying warrants (up to 66.67 million shares each)Action: Evaluate the impact on common share outstanding counts and EPS dilution
Research as of 20 Jun 2026